AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 39 filers reported holding AN2 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,517,552 | +213.6% | 1,089,400 | +65.8% | 0.70% | +261.5% |
| Q2 2023 | $5,586,200 | -21.7% | 657,200 | -9.1% | 0.20% | -17.7% |
| Q1 2023 | $7,137,984 | +0.7% | 723,200 | -2.7% | 0.24% | +53.9% |
| Q4 2022 | $7,086,508 | -45.1% | 743,600 | +0.1% | 0.15% | -41.2% |
| Q3 2022 | $12,907,000 | +141.9% | 742,630 | +7.9% | 0.26% | +114.8% |
| Q2 2022 | $5,335,000 | -48.6% | 688,330 | 0.0% | 0.12% | -43.5% |
| Q1 2022 | $10,373,000 | – | 688,330 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,773,517 | $37,244,613 | 0.84% |
| Monashee Investment Management LLC | 247,467 | $2,442,499 | 0.67% |
| BVF INC/IL | 1,563,963 | $15,436,315 | 0.56% |
| Avidity Partners Management LP | 723,200 | $7,137,984 | 0.24% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 52,500 | $518,175 | 0.01% |
| Alyeska Investment Group, L.P. | 48,426 | $477,965 | 0.00% |
| Citadel Advisors | 1,337,159 | $13,197,759 | 0.00% |
| Private Advisor Group, LLC | 22,008 | $217,219 | 0.00% |
| ETF MANAGERS GROUP, LLC | 6,742 | $66,544 | 0.00% |
| CITIGROUP INC | 134,473 | $1,327,249 | 0.00% |